BridgeBio Pharma Launches with a Focus on Precision Medicines for Genetic Diseases

PALO ALTO, Calif.–(BUSINESS WIRE)–California-based BridgeBio Pharma has come out of stealth mode to reveal more detail about its novel approach to developing new therapies for genetic diseases. These diseases, often inherited and individually rare, collectively exact devastating effects on tens of millions of patients in the US alone, many of whom are children. The company, […]